James Sapirstein

Affiliations

  • Chairman And Ceo at First Wave Biopharma Inc. (FWBI), 2024-04-03
  • Director at Renovaro Inc. (RENB), 2024-03-19
  • Director at Blue Water Biotech Inc. (BWV), 2023-06-02
  • Director at Zyversa Therapeutics Inc. (ZVSA), 2023-01-17
  • Interim Ceo at Marizyme Inc (MRZM), 2021-03-23
  • Director at Blue Water Acquisition Corp. (BLUW), 2020-12-16
  • Chief Executive Officer at Contravir Pharmaceuticals Inc. (CTRV), 2018-01-05
  • Director at Respirerx Pharmaceuticals Inc. (RSPI), 2017-12-13
  • Director at Probility Media Corp (PBYA), 2017-02-15
  • Ceo, Therapeutics Division at Alliqua Inc. (ALQA), 2014-01-17
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CTRV $1.00 10,000 Officer, Director 13,000 2016-02-18 Filing
CTRV $2.15 500 Officer, Director 3,000 2015-11-30 Filing
CTRV $1.64 2,500 Officer, Director 2,500 2015-11-23 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
FWBI $4.23 174 Officer, Director 37,105 2024-04-01 Filing
FWBI $4.96 1,887 Officer, Director 37,279 2024-03-15 Filing
FWBI $4.20 166 Officer, Director 39,166 2024-01-12 Filing
FWBI $0.29 2,764 Officer, Director 33,397 2023-10-04 Filing
FWBI $1.54 3,349 Officer, Director 36,161 2023-07-03 Filing